Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent advances in upstream process development for production of recombinant adeno‐associated virus

10 Sept 2023

Abstract excerpt

Recombinant adeno-associated virus (rAAV) is rapidly emerging as the preferred delivery vehicle for gene therapies, with promising advantages in safety and efficacy. Key challenges in systemic in-vivo rAAV gene therapy applications are the gap in production capabilities versus potential market demand and complex production process. This review summarizes current available information on rAAV upstream...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Viral Infectious Diseases and Gene Expression in Insects
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37691172
DOI: 10.1002/bit.28545

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent advances in upstream process development for production of recombinant adeno‐associated virusPMID 37691172Read ↗

Gene therapy: challenges in cell culture scale-upSemantic proximity Read ↗

Critical challenges and advances in recombinant adeno‐associated virus (rAAV) biomanufacturingSemantic proximity Read ↗

Perfusion‐Based Production of rAAV via an Intensified Transient Transfection ProcessSemantic proximity Read ↗

Continuous Production of rAAV via an Intensified Transient Transfection ProcessSemantic proximity Read ↗

Unravelling the essential elements for recombinant adeno-associated virus (rAAV) production in animal cell-based platformsSemantic proximity Read ↗

Manufacturing of recombinant adeno-associated viral vectors for clinical trialsSemantic proximity Read ↗

Manufacturing of viral vectors for gene therapy: part I. Upstream processingSemantic proximity Read ↗

Recent Advances in Therapeutics and Manufacturing Processes of Recombinant Adeno-Associated Virus for the Treatment of Lung DiseasesSemantic proximity Read ↗

Advancing AAV production with high-throughput screening and transcriptomicsSemantic proximity Read ↗

Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapiesSemantic proximity Read ↗

Development of an HEK293 Suspension Cell Culture Medium, Transient Transfection Optimization Workflow, and Analytics for Batch rAAV ManufacturingSemantic proximity Read ↗

Adenovirus–Adeno-Associated Virus Hybrid for Large-Scale Recombinant Adeno-Associated Virus ProductionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.